semaglutide target Semaglutide, exenatide, and their relatives are transforming diabetes and obesity care. Because their also sits on brain cells, research into whether they slow Alzheimer's and Parkinson's has exploded: from 2 papers Semaglutide Dosing - Doctor's Advice

doi: 10.1016/j.clinre.2016.12.007 29 MousaviTNikfarSAbdollahiM

Back Capozzi, ME, DiMarchi, RD, Tschp, MH, et al (13 June 2019) Targeting the incretin/glucagon system with triagonists to treat diabetes', Endocrine Reviews , 39/5, 719-38

Clinical trial in adolescents: A recent clinical trial showed that teens who were overweight or obese also lost weight on semaglutide

Semaglutide (Ozempic and Wegovy), along with other GLP-1 medications, works by mimicking a naturally occurring hormone in your body called glucagon-like peptide-1 (GLP-1)

Daily dosing provides consistent hormonal support, avoiding the fluctuations some patients experience with weekly injectable therapies